Western Regional Community Clinical Oncology Program

西部地区社区临床肿瘤学计划

• 批准号: 6619226
• 负责人: DAVID K KING
• 金额: $ 40.75万
• 依托单位: BANNER GOOD SAMARITAN MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 1983
• 资助国家: 美国
• 起止时间: 1983-09-01 至 2006-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6619226
• 关键词: antineoplastic antibiotics; aspirin; bone marrow transplantation; brain neoplasms; breast neoplasms; cancer information system; cancer prevention; cancer registry /resource; cancer rehabilitation /care; chemoprevention; clinical research; clinical trials; colony stimulating factor; combination cancer therapy; cooperative study; female reproductive system neoplasm; gastrointestinal neoplasms; health disparity; hormone therapy; human subject; human therapy evaluation; leukemia; lung neoplasms; lymphoma; medical rehabilitation related tag; medically underserved population; multiple myeloma; neoplasm /cancer chemotherapy; neoplasm /cancer education; neoplasm /cancer immunotherapy; neoplasm /cancer radiation therapy; neoplasm /cancer surgery; oncology nursing; primary care physician; prostate neoplasms; tumor necrosis factor alpha; urinary tract neoplasms

DESCRIPTION (provided by applicant): The Greater Phoenix CCOP is a consortium of five hospitals with 40 investigators, led by principal investigator, David King, MD. Dr. King and many of the investigators have been associated with the CCOP since its inception in 1982. The continuing long-term goals and specific aims of the GPCCOP include: 1) To increase clinical research activities with new and established research bases; 2) To participate in chemoprevention studies supported through other NCI mechanisms, to enhance offerings to GPCCOP's population; 4) To maintain and enhance quality assurance and pharmacy tools to support GPCCOP accrual; 5) To provide for human subject protection and minimal research risk; and 6) To support the disease prevention objectives of "Healthy People 2010" - in particular, to eliminate health disparities among different segments of the population through outreach, affiliations, and recruitment strategies focusing on minorities, women, and the underserved. GPCCOP's organizational structure requires the involvement of the investigators, hospital administrators from each of the participating component organizations and the staff in planning and policy-making decisions. The research activities and resources are split evenly between the treatment segment and the chemoprevention segment of GPCCOP, with each segment achieving accrual and quality goals established by the National Cancer Institute. GPCCOP's outreach is focused on achieving goals of minority and underserved accrual through community affiliations, collaborations, and geographical diversity. By establishing community and tribal partnerships, GPCCOP facilitates an outreach territory encompassing more that 40,000 square miles and 4 counties. GPCCOP's dedication to participant accrual (205 treatment and more than 1000 chemoprevention participants in the past five years), quality assurance, human subject protection, and minority outreach, as well as the devotion of resources from its consortium hospitals, demonstrate its preparedness to continue its active participation in NCI's Community Clinical Oncology Program.

描述(由申请人提供)：大凤凰CCOP是一个由五家医院组成的联盟，有40名调查员，由首席调查员大卫·金领导。自1982年CCOP成立以来，金博士和许多调查人员一直与其有联系。GPCCOP持续的长期目标和具体目标包括：1)通过新的和建立的研究基地增加临床研究活动；2)参与通过其他NCI机制支持的化学预防研究，以加强向GPCCOP人口提供的服务；4)保持和加强质量保证和药剂学工具，以支持GPCCOP的应计；5)提供人体受试者保护和将研究风险降至最低；以及6)支持“2010年健康人”的疾病预防目标--特别是通过以少数群体、妇女和未得到充分服务的人群为重点的外联、联系和招募战略，消除不同人口群体之间的健康差距。GPCCOP的组织结构要求调查人员、每个参与组织的医院管理人员和工作人员参与规划和决策。研究活动和资源平均分配到GPCCOP的治疗部分和化学预防部分，每个部分都实现了国家癌症研究所制定的应计和质量目标。GPCCOP的外展重点是通过社区联系、合作和地理多样性实现少数群体和服务不足的目标。通过建立社区和部落伙伴关系，GPCCOP促进了覆盖40,000多平方英里和4个县的外展领土。GPCCOP致力于参与者应计(在过去五年中有205项治疗和1000多名化学预防参与者)、质量保证、人类受试者保护和少数群体宣传，以及其联盟医院的资源投入，表明其准备继续积极参与NCI的社区临床肿瘤学计划。